程序性细胞死亡蛋白1(PD-1)检查点阻断联合哺乳动物雷帕霉素靶蛋白抑制剂抑制由肝癌细胞内在PD-1诱导的肝细胞癌生长
在免疫缺陷异种移植小鼠中,肝癌细胞内在的PD-1表达不依赖适应性免疫促进肿瘤生长;敲低PD-1抑制肿瘤生长,过表达PD-1增强致瘤性。PD-1结合下游哺乳动物雷帕霉素靶蛋白效应分子eIF4E和核糖体蛋白S6并促进其磷酸化;雷帕霉素靶蛋白抑制联合抗PD-1抗体治疗比任一单药产生更持久且协同的肿瘤消退。
要点
- 肝癌细胞内在PD-1表达不依赖适应性免疫促进肿瘤生长。
- 敲低PD-1抑制肿瘤生长,过表达PD-1增强免疫缺陷小鼠致瘤性。
- 雷帕霉素靶蛋白抑制联合抗PD-1抗体比单药产生更持久协同的肿瘤消退。
核心结论
- 靶向哺乳动物雷帕霉素靶蛋白通路联合PD-1可能提高癌症患者的抗肿瘤疗效。
研究设计与样本
- 研究在免疫缺陷异种移植小鼠中采用PD-1敲低和过表达模型,并比较雷帕霉素靶蛋白抑制联合抗PD-1抗体与任一单药的疗效。
主要发现
- 敲低PD-1抑制肿瘤生长,而PD-1过表达增强免疫缺陷异种移植小鼠的致瘤性。
- PD-1结合下游哺乳动物雷帕霉素靶蛋白效应分子真核起始因子4E和核糖体蛋白S6,促进其磷酸化。
- 雷帕霉素靶蛋白抑制联合抗PD-1抗体治疗比任一单药产生更持久且协同的肿瘤消退,而任一单药仅呈现 modest 疗效。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Inhibitors of programmed cell death 1 (PD-1) administered as single agents have resulted in durable tumor regression in advanced cancer patients. However, only a minority of cancer patients respond to anti-PD-1 immunotherapy. Here, we show that PD-1 expression in hepatocellular carcinoma promotes tumor growth independently of adaptive immunity. Knockdown of PD-1 suppresses tumor growth, whereas PD-1 overexpression enhances tumorigenesis in immunodeficient xenografted mice. Mechanistically, PD-1 binds the downstream mammalian target of rapamycin effectors eukaryotic initiation factor 4E and ribosomal protein S6, thus promoting their phosphorylation. Moreover, combining mammalian target of rapamycin inhibition with anti-PD-1 antibody treatment results in more durable and synergistic tumor regression than either single agent alone, each of which presents only modest efficacy. CONCLUSION: Targeting mammalian target of rapamycin pathways in combination with PD-1 may result in increased antitumor efficacy in cancer patients. (Hepatology 2017;66:1920-1933).
引用
- Li H, Li X, Liu S, et al. Programmed cell death-1 (PD-1) checkpoint blockade in combination with a mammalian target of rapamycin inhibitor restrains hepatocellular carcinoma growth induced by hepatoma cell-intrinsic PD-1. Hepatology. 2017. PMID: 28732118. doi:10.1002/hep.29360
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。